John McNichol, Contributor at the TD Ameritrade Network goes over three overlooked stocks. First, Neurometrix (NURO) is up 150% after their nerve stimulation device won FDA breakthrough designation for fibromyalgia. Next, Beyond Air (XAIR), which is a clinical-stage medical device and biopharmaceutical company, hit a 52-week high today. Finally, Shift4 Payments (FOUR) shares are lower after news of their public offering. Tune in to find out more.
21 Jul 2021
The Watch List
12 Jul 2022
Next Gen Investing
17 Jun 2022
Morning Trade Live
17 Jun 2022
Next Gen Investing
27 Jun 2022
Morning Trade Live
27 Jun 2022
Futures
21 Jun 2022